Remove 2022 Remove Ablation Remove Atrial Fibrillation
article thumbnail

Pulsed field ablation for atrial fibrillation: a comprehensive bibliometric analysis of research trends and emerging Frontiers

Frontiers in Cardiovascular Medicine

BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues.

article thumbnail

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.

article thumbnail

Effect of sacubitril/valsartan on sinus rhythm maintenance after catheter ablation in patients with persistent atrial fibrillation without reduced ejection fraction heart failure: a study protocol for a multi-center, open-label, randomized, controlled, superiority clinical trial

Frontiers in Cardiovascular Medicine

Introduction A high recurrence rate of atrial fibrillation was monitored after catheter ablation for persistent atrial fibrillation. Trial Registration Registered with Chinese Clinical Trials Registry on 27 August 2022, identifier: ChiCTR2200062995.

article thumbnail

Optimized workflow for paroxysmal atrial fibrillation ablation using very high power short duration

Frontiers in Cardiovascular Medicine

Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrial fibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.

article thumbnail

Pulsed?field ablation does not induce esophageal and periesophageal injury—A new esophageal safety paradigm in catheter ablation of atrial fibrillation

Journal of Cardiovascular Electrophysiology

Better tissue selectivity of primarily non-thermic pulsed field ablation (PFA) may eliminate collateral injury, particularly the risk of atrio-esophageal fistula (AEF). Following PFA-PVI, none of the patients had mucosal lesions, food retention, or ablation-induced vagal nerve injury; four patients showed periesophageal edema.

article thumbnail

BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

DAIC

Procedures that leverage transseptal delivery include atrial fibrillation ablation , patent foramen ovale (PFO) and atrial septal defect (ASD) repair, percutaneous mitral valve repair, left atrial appendage closure, and percutaneous left ventricular assist device placement, among others.

article thumbnail

Abstract TP283: Incidence of Stroke in Patients with AF and history of Catheter Ablation

Stroke Journal

Introduction:Catheter ablation (CA) is superior to medical therapy in the management of atrial fibrillation (AF). The median follow-up duration for the patient population was 1168 days post-ablation. Catheter ablation was presumed successful in 19/32 patients who experienced a CVA. Conclusions:CVA occurred in 1.4%